Zosano Pharma Corporation (ZSANQ)

OTCMKTS: ZSANQ · Delayed Price · USD
0.290
-0.030 (-9.38%)
Jun 28, 2022 4:00 PM EDT - Market closed
-9.38%
Market Cap 1.42M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 4.90M
EPS (ttm) -15.69
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,121
Open 0.287
Previous Close 0.320
Day's Range 0.280 - 0.320
52-Week Range 0.250 - 0.550
Beta 3.29
Analysts n/a
Price Target n/a
Earnings Date Aug 8, 2022

About ZSANQ

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy C... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Jan 27, 2015
CEO Steven Lo
Employees 40
Stock Exchange OTCMKTS
Ticker Symbol ZSANQ
Full Company Profile

Financial Performance

In 2021, Zosano Pharma's revenue was $785,000, an increase of 250.45% compared to the previous year's $224,000. Losses were -$29.93 million, -10.32% less than in 2020.

Financial Statements

News

Why Zosano Pharma Shares Are Getting Hammered Today

Zosano Pharma Corp (NASDAQ: ZSAN) shares are trading lower by 44.35% at $0.98 after the company announced it filed a voluntary petition for relief under chapter 11. Zosano says the company continues to ...

Zosano Pharma Reports First Quarter 2022 Financial Results

FREMONT, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March...

Zosano Pharma Announces Additional Workforce Layoff

The FDA had granted Zosano Pharma Corporation (NASDAQ: ZSAN) a twelve-month extension to April 20, 2023, to resubmit its M207 marketing application. However, to preserve its capital and cash resources, ...

Zosano Pharma Provides Corporate Update

FREMONT, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today provided a corporate update.

Is Zosano Pharma (ZSAN) Stock Really Up 3,000% Today?

ZSAN stock appears to be soaring because the company carried out a reverse stock split in order to stay compliant with the Nasdaq's rules. The post Is Zosano Pharma (ZSAN) Stock Really Up 3,000% Today?

Zosano Pharma Announces Reverse Stock Split Effective Today

ZSAN common stock expected to begin trading on a split-adjusted basis on April 12, 2022 ZSAN common stock expected to begin trading on a split-adjusted basis on April 12, 2022

Best Stocks to Buy Under $5? Check These 3 Out

Are these the best penny stocks to watch under $5 right now? The post Best Stocks to Buy Under $5?

Other symbols: ESOASOS

Zosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial Results

FREMONT, Calif., March 17, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter and year...

FDA Rejects Zosano Pharma's Application For Zolmitriptan Microneedle System Again, Shares Plunge

The FDA has issued a response letter to Zosano Pharma Corp (NASDAQ: ZSAN) regarding its resubmission of the 505(b)(2) New Drug Application for M207 (zolmitriptan microneedle system).  The response lette...

Zosano Pharma Announces Pricing of $15.4 Million Public Offering of Common Stock and Warrants

FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the pricing of its previously announced underwritt...

Zosano Pharma Announces Proposed Public Offering of Common Stock and Warrants

FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it is commencing an underwritten public offer...

CORRECTION - Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trival...

—Data published in the Journal of Vaccines and Immunology— —Data published in the Journal of Vaccines and Immunology—

Zosano Pharma Announces Publication Of Early Data On Influenza Vaccine

Zosano Pharma Corporation (NASDAQ: ZSAN) announced the publication of Phase 1 trial data of influenza vaccine in the Journal of Vaccines and Immunology.  The data demonstrated that a low dose of a triva...

Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza...

—Data published in the Journal of Vaccines and Immunology— —Data published in the Journal of Vaccines and Immunology—

Zosano Pharma Announces Changes to Board of Directors; Appoints Cross Functional Business Executive Elaine M. Yang

FREMONT, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced changes to its board of directors, including the a...

Today's Hot Penny Stocks: What's Moving ZSAN, AVGR and CEI Higher Wednesday?

Today's hot penny stocks are catching the eyes of investors and we're diving into everything investors need to know about them on Wednesday! The post Today's Hot Penny Stocks: What's Moving ZSAN, AVGR a...

Other symbols: AVGRCEI

Zosano Pharma Corporation (ZSAN) Reports Q3 Loss, Misses Revenue Estimates

Zosano Pharma Corporation (ZSAN) delivered earnings and revenue surprises of 0.00% and -10.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the s...

Zosano Pharma Reports Third Quarter 2021 Financial Results

FREMONT, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended Sept...

Zosano Pharma Granted Type C Meeting with FDA Regarding NDA Resubmission for M207 Following Preliminary Top-Line Phar...

FREMONT, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the company has been granted a Type C written resp...

Zosano Pharma to Present at the H.C. Wainwright Virtual Global Investment Conference

FREMONT, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer, S...

Zosano Pharma Corporation (ZSAN) Reports Q2 Loss, Misses Revenue Estimates

Zosano Pharma Corporation (ZSAN) delivered earnings and revenue surprises of 0.00% and -30.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Zosano Pharma Reports Second Quarter 2021 Financial Results

FREMONT, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the second quarter ended Jun...

7 Most Promising Penny Stocks to Achieve Your Multibagger Dreams

Penny stocks are a great entry into the market. Here are seven that have the potential to provide quick returns with their strong catalysts.

Other symbols: GPLREISENSXELA

Zosano Pharma Announces Issuance of U.S. Patent for Method of Rapidly Achieving Therapeutic Levels with M207 for the ...

FREMONT, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has been granted an additional patent cove...

3 Biopharma Penny Stocks That Could be Millionaire Makers

These three biotech penny stocks all have developed drugs that have shown strong indications of success. The post 3 Biopharma Penny Stocks That Could be Millionaire Makers appeared first on InvestorPlace.

Other symbols: CLSNVTVT